mifepristone

Key facts

INN

mifepristone

Brand

MIFEPRISTONE

Route

ORAL

Formulation

TABLET

Originator

TEVA PHARMACEUTICAL INDUSTRIES LTD

Related patents

patent

US 11173165

Optimizing mifepristone levels for Cushing's patients

Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10842801

Optimizing mifepristone absorption

Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10660904

Optimizing mifepristone levels for cushing's patients

Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10500216

Optimizing mifepristone absorption

Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10166242

Optimizing mifepristone levels for Cushing's patients

Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10166243

Optimizing mifepristone levels for cushing'S patients

Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9943526

Optimizing mifepristone levels for cushing's patients

Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 8921348

Optimizing mifepristone levels in plasma serum of patients suffering from mental

Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is mifepristone?

mifepristone (MIFEPRISTONE), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

What is the brand name for mifepristone?

MIFEPRISTONE is a marketed brand name for mifepristone. Check FDA Drugs@FDA for the current US label holder.